- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer in Italy
Total 628 results
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
ETOP IBCSG Partners FoundationEuropean Organisation for Research and Treatment of Cancer - EORTC; AmgenTerminatedLung Cancer Non-small Cell Stage IVIreland, Spain, Switzerland, United Kingdom, France, Austria, Slovenia, Belgium, Italy, Germany, Poland
-
AstraZenecaParexelWithdrawnNon Small Cell Lung CancerItaly, Russian Federation, Spain, China, Netherlands, United States, Taiwan, France, Germany
-
Gruppo Oncologico Italiano di Ricerca ClinicaIqvia Pty Ltd; AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations... and other collaboratorsCompletedNon-Small Cell Lung CancerItaly
-
European Institute of OncologyAssociazione Italiana per la Ricerca sul CancroRecruiting
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase (ALK)Australia, Spain, Singapore, Italy, United States
-
Hoffmann-La RocheRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Canada, Turkey, Brazil, Spain, France, Germany, Australia, Italy, Belgium, Mexico
-
Threshold PharmaceuticalsEMD SeronoTerminatedNon-small Cell Lung CancerUnited States, Germany, Spain, Poland, Greece, Czechia, Hungary, Italy, Romania, Russian Federation
-
AstraZenecaDaiichi SankyoRecruitingAdvanced or Metastatic NSCLCUnited States, Taiwan, Italy, Poland, Spain, Japan, Belgium, Turkey, France, Korea, Republic of
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
TakedaCompletedCarcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid TumorsSpain, Italy, Netherlands, France
-
AstraZenecaCompletedNon Small Cell Lung CancerUnited States, Belgium, France, Italy, Spain, Canada, Brazil, Hungary, Peru, Czechia, Bulgaria, Mexico
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, Taiwan, United Kingdom, Philippines, Latvia, Italy, Israel, Argentina, Mexico, Germany, Malaysia
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
Dizal PharmaceuticalsRecruitingNon-small Cell Lung CancerChina, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, Turkey
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaboratorsCompletedNon Small Cell Lung CancerBelgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingNon-small Cell Lung CancerPoland, United States, New Zealand, Australia, Costa Rica, Taiwan, Argentina, France, Chile, Hungary, Spain, Greece, Canada, Lithuania, Norway, Italy, Czechia, Estonia, Portugal
-
Eli Lilly and CompanyCompletedA Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNon-Small Cell Lung Cancer Stage IVUnited States, Italy, Spain, Australia, France, Germany, Hungary, Korea, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung CarcinomaItaly, United Kingdom
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
Angiodynamics, Inc.CompletedPulmonary Metastases | Non Small Cell Lung CancerUnited States, United Kingdom, Italy, Germany, Australia
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerUnited States, Spain, China, France, Canada, Italy
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerItaly, Spain, Netherlands, France, Germany, United Kingdom
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
AstraZenecaParexelRecruitingNon-small Cell Lung CancerHungary, United States, Italy, Belgium, Spain, France, Korea, Republic of, Taiwan, Turkey, Ireland, Portugal, Canada
-
Philogen S.p.A.CompletedBreast Cancer | Solid Tumor | Metastatic Melanoma | Non-small Cell Lung Cancer (NSCLC)Italy
-
Summit TherapeuticsAkesoRecruitingNon-Squamous Non-small Cell Lung CancerCanada, United States, Spain, Italy, France, United Kingdom
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
AnHeart Therapeutics Inc.RecruitingNon Small Cell Lung CancerUnited States, Spain, France, Italy, Japan, Korea, Republic of, Canada, China, Poland
-
Eli Lilly and CompanyUniversity of Colorado, Denver; PPD; Parexel; ICON Clinical Research; Laboratory... and other collaboratorsActive, not recruitingNon Small Cell Lung CancerUnited States, Belgium, Brazil, Russian Federation, Serbia, Spain, United Kingdom, Germany, Australia, Hungary, Italy, Romania, Austria, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Philippines, Canada, Korea,... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerFrance, Germany, Spain, Sweden, Russian Federation, Greece, Switzerland, Korea, Republic of, Italy, Netherlands, Turkey, United Arab Emirates
-
PfizerActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Netherlands, Korea, Republic of, Italy
-
GenmabMerck Sharp & Dohme LLC; BioNTech SERecruitingNon Small Cell Lung Cancer MetastaticUnited States, Spain, Netherlands, Italy, France, United Kingdom, Poland, Germany, Portugal
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, Japan, France, Hungary, Netherlands
-
Gilead SciencesMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Italy, France, Australia, Hong Kong, Korea, Republic of, Malaysia, Taiwan, Germany, United Kingdom, Canada
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | Non Small Cell Lung CancerUnited States, Spain, France, Belgium, Italy, Taiwan, Turkey
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
Regeneron PharmaceuticalsSanofiActive, not recruitingNon-small Cell Lung CancerUnited States, France, Korea, Republic of, Italy, Austria, China, Georgia, Greece, Ireland, Lithuania, Malaysia, Poland, Romania, Russian Federation, Slovakia, Thailand, Turkey, Ukraine
-
AstraZenecaTerminatedBrain Neoplasms | Non Small Cell Lung CancerItaly
-
Hoffmann-La RocheTerminatedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Belgium, Germany, Spain, Australia, Canada, United Kingdom, France, Poland, Ireland
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerFrance, Italy, United Kingdom, Hungary, Belgium, Canada, Spain, Germany, Singapore, Netherlands, Thailand, United States, Turkey, Argentina, Brazil, Hong Kong, Japan, Taiwan
-
Fatebenefratelli and Ophthalmic HospitalNiguarda Hospital; Mario Negri Institute for Pharmacological ResearchUnknown